• 대한한방종양학회지
• /
• 제3권1호
• /
• pp.67-84
• /
• 1997

Bujeonghangamtang(扶正抗癌湯) has been used for cure of tumor as a traditional medicine without any experimental evidence to support the rational basis for its clinical use. This study was carried out to evaluate the possible therapeutic or antitumoral effects of Bujeonghangamtang extract against tumor, and to carry out some mechanisms responsible for its effect. Some kinds of tumor were induced by the typical application of 3-methylcholanthrene. (MCA) or by the implantation(s.c) of malignant tumor cells such as leukemia cells(3LL cells) or sarcoma cells(Sl80 cells). Treatment of the Bujeonghangamtang water-extract (dailly 1mg／mouse, i. p.) was continued for 7 days prior to tumor induction and after that the treatment was lasted for 20 days. Against squamous cell carcinoma induced by MCA, Bujeonghangamtang decreased not only the frequency of tumor production but also the number and the weight of tumors per tumor bearing mice (TBM). Bujeonghangamtang also significantly suppressed the development of 3LL cell and S180 cell-implanted tumors in occurrence-frequency and their size, and some developed tumors were regressed by the continuous treatment of Bujeonghangamtang extract into TBM. In vitro, treatment of Bujeonghangamtang extract had no effect on the growth of some kinds of cell line such as FsaII, A431 strain but significantly inhibited the proliferation of 3LL, S180 cells and augmented the DNA synthesis of mitogen-activated lymphocytes. Bujeonghangamtang also stimulated the migrative ability of leukocyte, the MIF and IL-2 production of T lymphocytes, but not IL 6 production of B cells. Bujeonghangamtang-administration to mice enhanced NK cells activities. These results demonstrated that Bujeonghangamtang extract exhibited a significant prophylactic benefits against tumors and its antitumor activity was manifested depending on the type of tumor cells. And these results also suggested that effect of Bujeonghangamtang might be chiefly due to nonspecific enhancement of NK cell activities and cell-mediated immune responses.

• Bulletin of the Korean Chemical Society
• /
• 제34권2호
• /
• pp.482-488
• /
• 2013

Two piperazine-containing 3,4-dihyroquinazolines (BK10007S/8S) have been synthesized, based on our previous work on the synthesis and antitumoral activity of 3,4-dihyroquinazolines. After evaluating them for T-type calcium channel blocking effect and in vitro anti-cancer effect, they were profiled for acute and repeat dose toxicity (40 mg/kg, 2 weeks) to BALB/c mice. BK10007S/8S were further in vivo evaluated against human pancreatic MIA PaCa-2 carcinoma in $BALB/c^{nu/nu}$ nude mice, which exhibited 54 and 61% tumor growth inhibition through 57-day oral administration of 2 mg/kg of body weight, respectively.

• 한국식품저장유통학회지
• /
• 제8권4호
• /
• pp.481-487
• /
• 2001

본 연구에서는 다양한 기능성을 가지는 저령을 80% methanol로 추출한 후 그 농축액을 ehyl acetate와 water로 순차 분획하고, 각 분획물을 이용하여 인간유래 위암세포인 SNU668의 생장 저해 효과와 항산화 효과 및 각종 위장질환의 원인균으로 보고된 H. pylori에 대한 항균활성을 조사하였다. 인간유래의 위암세포인 SNU668에 대한 저해 효과는 methanol fraction 1 mg/$m\ell$의 농도에서 가장 강한 암세포 저해 활성을 보였고, water fraction 1 mg/$m\ell$의 농도에서는 43.9%의 저해 활성을 보였다. 그러나 ethyl acetate fraction에서는 23.7%로 비교적 낮은 저해율을 보였다. 반면에, 성인 남성의 정상 임파구는 분획종류에 관계없이 모두 90% 이상의 높은 생존율을 보였다. 한편, 저령 추출물의 항산화 효과는 생존을 75.2%를 보인 methanol 추출물이 43.7%의 생존율을 보인 water 분획물 보다 높았고, ethyl acetate 분획물은 항산화 효과 역시 가장 낮게 나타났다. H. pylori에 대한 저령의 항균활성은 1mg/disk의 농도에서 80% methanol 추출물 및 모든 분획물에서 H. priori에 대해 항균활성을 나타냈으며, 그중 water 분획물이 12mm의 inhibition zone을 형성하여 가장 우수한 항균활성을 보였다. Methanol 추출물과 ethyl acetate 분획물은 각각 11 및 9.5 mm의 inhibition zone을 형성하였다. H. pylori로부터 분리된 urease의 활성은 urea broth에서의흡광도와 pH의 변화를 조사한 결과, 23$^{\circ}C$에서 반응 1시간 동안 560 nm에서의 흡광도가 0에서 0.93까지 증가하였으며, pH는 7.0으로부터 8.1까지의 증가를 보였다. H.pylori로부터 분리된 urease의 활성은 80% methanol 추출물과 모든 분획물에 의해 억제되었으며, 각 분획물의 억제능은 항균실험 결과와 유사한 유형으로서 역시 10mg/$m\ell$의 농도에서 1시간 후 55%의 억제를 보인 water분획물의 억제능이 가장 우수했다.

• 대한한의학회지
• /
• 제19권1호
• /
• pp.234-250
• /
• 1998

Bujeonghangamtang(扶正抗癌湯) has been used for cure of tumor as a traditional medicine without any experimental evidence to support the rational basis for its clinical use. This study was carroed out to evaluate the possible therapeutic or antitumoral effects of Bujeonghangamtang extract against tumor, and to carry out some mechanisms responsible for its effect. Some kinds of tumor were induced by .the typical application of 3-methylcholanthrene (MCA) or by the implantation(s.c) of malignant tumor cells such as leukemia cells(3LL cells) or sarcoma cells(Sl80 cells). Treatment of the Bujeonghangamtang water-extract (dailly 1mg/mouse, i. p.) was continued for 7 days prior to tumor induction and after that the treatment was lasted for 20 days. Against squamous cell carcinoma induced by MCA, Bujeonghangamtang decreased not only the frequency of tumor production but also the number and the weight of tumors per tumor bearing mice (TBM). Bujeongmngamtang also significantly suppressed the development of 3LL cell and S180 cell-implanted tumors in occurence-frequency and their size, and some developed tumors were regressed by the continuous treatment of Bujeonghangamtang extract into TBM. In vitro, treatment of Bujeonghangamtang extract had no effect on the growth of some kinds of cell line such as FsaII, A431 strain but significantly inhibited the proliferation of 3LL, S180 cells and augmented the DNA synthesis of mitogen-activated lymphocytes. Bujeonghangamtang also stimulated the migrative ability of leukocyte, the MIF and IL-2 production of T lymphocytes, but not IL 6 production of B cells. Bujeonghangamtang-administration to mice enhanced NK cells attivities. These results demonstrated that Bujeonghangamtang extract exhibited a significant prophylactic benefits against tumors and its antitumor activity was manifested depending on the type of tumor cells. And these results also suggested that effect of Bujeonghangamtang might be chiefly due to nonspecific enhancement of NK cell activities and cell-mediated immune responses.

• 동의생리학회지
• /
• 제14권2호통권20호
• /
• pp.229-237
• /
• 1999

Hwanhonsan has been used for curing tumor as a Oriental medicine without any experimental evidence to support the rational basis for their clinical use. This experiment was carried out to evaluate the possible therapeutic or antitumoral effects of Hwanhonsan extract against cancer, and to study some mechanisms responsible for its effect. Some kind of tumors were induced by the typical application of 3-methylcholanthrene(MCA) or by the implantation of malignant tumor cells such as leukemia cells(3LL cells) or sarcoma cells(S180 cells) and FasII cells. Treatment of the Hwanhonsan extract(daily 1 mg/mouse, i.p.) was continued for 7 days prior to tumor induction and after that the treatment was lasted for 20 hrs. Against squamous cell carcinoma induced by MCA, Hwanhonsan decreased. not only the frequency of tumor production but also the number and weight of tumors per tumor bearing mice(TBM). Hwanhonsan also significantly suppressed the development of 3LL cells and S180 cells implanted tumors by frequency and their size, and some developed tumors were regressed by the continuous treatment of Hwanhonsan extract into TBM. However, when tumor was induced by FsaII cells implantation, the growth of implanted cells in mice was delayed by the water extract of Hwanhonsan until 7 days and then rapid growth ensued. In vitro treatment of Hwanhonsan extract had no inhibitory effect on the tumor induced by some kind of cell lines such as A431 cells strain but it significantly inhibited the proliferation of 3LL cells, S180 cells. These results suggested that Hwanhonsan extract exhibited a significant prophylactic benefits against tumors and its antitumor activity was manifested depending on the type of tumor cells.

• 한국식품조리과학회지
• /
• 제22권6호통권96호
• /
• pp.914-922
• /
• 2006

본 연구는 로즈마리를 이용한 전통발효주를 개발하기 위하여 발효기간(0${\sim}$20일)에 따라 로즈마리 첨가량 (0, 10, 20, 30%)을 달리한 발효주의 품질특성을 살펴보았다. pH는 담금 5일째 급격히 감소하였으나 담금 5일 이후부터는 완만한 감소 추세로 나타났고 10% 로즈마리 첨가 발효주의 pH 감소가 가장 크게 나타났다. 적정산도는 pH 변화 양상과 부합한 결과가 나타났다. 총산은 담금 5일에 로즈마리 무첨가 발효주는 365.24mg%, 로즈마리 첨가 발효주는 376.52${\sim}$417.95 mg%로 급격히 증가하였으며 10% 로즈마리 첨가 발효주의 중가가 가장 크게 나타났다. 환원담은 담금 5일째 급격히 증가하였으며 로즈마리 무첨가 발효주가 로즈마리첨가 발효주보다 증가가 크게 나타났고 특히 30% 로즈마리 첨가 발효주가 가장 크게 증가하는 것으로 나타났다. 총당은 발효기간에 따라 로즈마리 무첨가 발효주가 로즈마리 첨가 발효주보다 총당 함량이 낮았으며 로즈마리 함량이 많을수록 총당 함량이 크게 나타났다. 알코올 함량은 담금 5일째 급격히 증가하였고 그 이후 완만한 증가 추세를 나타내었으며 로즈마리 무첨가 발효주가 로즈마리 첨가 발효주보다 알코올 함량이 낮았으며 로즈마리 함량이 많을수록 알코올 함량이 크게 나타났다. 전반적인 명도를 나타내는 L값의 경우 10% 로즈마리 첨가 발효주를 제외한 발효주는 발효기간에 따라 증가, 감소하는 경향이 반복하는 것으로 나타났고 적색도를 나타내는 a값의 경우 로즈마리 무첨가 발효주는 발효기간에 따라 증가하였으나 로즈마리 첨가 발효주는 로즈마리 첨가량과 관계없이 증가, 감소하는 경향이 반복하는 것으로 나타났다. 황색도를 나타내는 b값의 경우 발효기간에 따라 로즈마리첨가 유무에 상관없이 감소, 증가하는 경향이 반복하는 것으로 나타났다. 투과도는 발효기간에 따라 감소하였으나 로즈마리 첨가량에 따라서는 첨가량이 많을수록 투과도가 높게 나타났다. Amylase 활성도는 담금5일째 로즈마리 첨가 유무에 상관없이 급격히 증가하였다가 감소하였으며 로즈마리 첨가량이 증가할수록 amylase 활성도는 감소하는 것으로 나타났다.